Invokanamet Trademark Details
Word Mark | Invokanamet |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 85758907 |
---|---|
Status Date | Monday, December 29, 2014 |
Filing Date | Monday, December 29, 2014 |
Attorney | Cheryl L. Foytlin |
Correspondent
CHERYL L. FOYTLIN
Johnson & Johnson
1 JOHNSON AND JOHNSON PLZ
NEW BRUNSWICK NJ 08933-0001
Johnson & Johnson
1 JOHNSON AND JOHNSON PLZ
NEW BRUNSWICK NJ 08933-0001
Case File Statements
Goods & Services | Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, October 24, 2012 |
Primary Code | 005 |
Trademark Timeline
-
Oct 19 2012Trademark application filed with USPTO
-
Oct 23 2012New Application Entered In Tram
-
Oct 24 2012New Application Office Supplied Data Entered In Tram
-
Feb 15 2013Assigned To Examiner
-
Feb 22 2013Approved For Pub - Principal Register
-
Mar 13 2013Notification of Notice of Publication E-Mailed
-
Apr 02 2013Official Gazette Publication Confirmation E-Mailed
-
Apr 02 2013Published For Opposition
-
May 28 2013Noa E-Mailed - Sou Required From Applicant
-
Nov 06 2013Extension 1 Granted
-
Nov 06 2013Extension 1 Filed
-
Nov 06 2013Teas Extension Received
-
Nov 06 2013Teas Change of Correspondence Received
-
Nov 08 2013Notice of Approval of Extension Request E-Mailed
-
May 01 2014Extension 2 Filed
-
May 01 2014Teas Extension Received
-
May 23 2014Case Assigned To Intent To Use Paralegal
-
May 27 2014Extension 2 Granted
-
May 28 2014Notice of Approval of Extension Request E-Mailed
-
Dec 29 2014Abandonment Notice Mailed - No Use Statement Filed
-
Dec 29 2014Abandonment - No Use Statement Filed